Benzinga - Thu, 06 May 2021 16:50:44 -0400
Benzinga - Wed, 21 Apr 2021 10:35:05 -0400
Benzinga - Wed, 21 Apr 2021 07:05:19 -0400
Benzinga - Tue, 20 Apr 2021 16:48:29 -0400
Benzinga - Tue, 20 Apr 2021 11:11:54 -0400
load more
Sector: Health Care.Industry: Pharmaceuticals
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-21
REV
Q4 2020Est.ActualSurprise
EPS-0.040
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
HOTHHoth Therapeutics-1.33%33.8M

Hoth Therapeutics Company Questions & Answers

Q

How do I buy Hoth Therapeutics (HOTH) stock?

A

You can purchase shares of Hoth Therapeutics (NASDAQ: HOTH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Hoth Therapeutics's (HOTH) main competitors?

A

Other companies in Hoth Therapeutics’s space includes: Teligent (NASDAQ:TLGT), Pulmatrix (NASDAQ:PULM) and Cumberland (NASDAQ:CPIX).

Q

What is the target price for Hoth Therapeutics?

A

The latest price target for Hoth Therapeutics (NASDAQ: HOTH) was reported by Benchmark on 2019-10-15. The analyst firm set a price target for 10.00 expecting HOTH to rise to within 12 months (a possible 575.68% upside). 0 analyst firms have reported ratings in the last year.

Q

How much is Hoth Therapeutics (HOTH) stock ?

A

The stock price for Hoth Therapeutics (NASDAQ: HOTH) is $1.48 last updated Fri May 07 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Hoth Therapeutics (HOTH) dividend?

A

There are no upcoming dividends for Hoth Therapeutics.

Q

When is Hoth Therapeutics (NASDAQ:HOTH) reporting earnings?

A
Hoth Therapeutics’s Q1 earnings are confirmed after-market from now on May 21, 2021.
Q

When is the upcoming split for HOTH?

A

There is no upcoming split for Hoth Therapeutics.